In a study published online in theNeurobiology of Aging, the compound MDA7, a CB2 cannabinoid receptor agonist, induced beneficial immune responses that limited the development of Alzheimer's disease. Treatment with the compound restored cognition, memory and synaptic plasticity -- a key neurological foundation of learning and memory -- in an animal model.
No comments:
Post a Comment